Table 2 Baseline characteristics in patients with or without treadmill exercise testing
From: Impaired chronotropic response to physical activities in heart failure patients
TET (N = 26) | No TET (N = 14) | P value | |
|---|---|---|---|
Age (years) | 52.8 ± 12.4 | 57.5 ± 9.4 | 0.233 |
Weight (Kg) | 76.3 ± 19.4 | 72.0 ± 13.0 | 0.471 |
Male, N (%) | 20 (76.9) | 10 (71.4) | 0.702 |
LVEF (%) | 43.9 ± 5.7 | 45.8 ± 5.9 | 0.346 |
NYHA class | 2.1 ± 0.5 | 2.3 ± 0.7 | 0.318 |
LVESD (mm) | 47.5 ± 6.5 | 42.8 ± 8.5 | 0.062 |
LVEDD (mm) | 60.5 ± 6.8 | 57.2 ± 8.8 | 0.208 |
6MHW (m) | 451.4 ± 61.8 | 344.1 ± 83.9 | <0.001 |
BNP (pg/mL) | 119.4 ± 123.8 | 119.8 ± 336.1 | 0.294 |
CAD, N (%) | 9 (34.6) | 5 (35.7) | 0.945 |
Cardiomyopathy, N (%) | 23 (88.5) | 12 (85.7) | 0.802 |
Β-blocker, N (%) | 25 (96.2%) | 13 (92.9) | 0.648 |